Short Wave A Revolutionary Experiment To Edit Human Genes
Nov 4, 2019
Rob Stein, an NPR health correspondent, shares the inspiring story of Victoria Gray, the first U.S. patient to receive CRISPR gene-editing for sickle cell disease. They discuss the physical and emotional struggles she faced as a mother living with this debilitating condition. The conversation dives into the revolutionary CRISPR technology that transformed her cells into healthier versions, offering hope to millions. Ethical questions around gene therapy and the future of genetic treatment are also explored, highlighting both the promise and challenges of this groundbreaking science.
AI Snips
Chapters
Transcript
Episode notes
Victoria Gray's Sickle Cell Struggle
- Victoria Gray, a 34-year-old stay-at-home mom, experiences severe pain and debilitation from sickle cell disease.
- Her son fears her death due to the disease's impact.
CRISPR Offers Hope for Sickle Cell
- Sickle cell disease affects millions globally, causing misshapen red blood cells that disrupt blood flow.
- Victoria Gray is the first U.S. patient undergoing CRISPR treatment for sickle cell, a potential game-changer.
Monitoring Fetal Hemoglobin
- Doctors monitor Victoria Gray's fetal hemoglobin production post-CRISPR treatment.
- Increased fetal hemoglobin could improve red blood cell health and overall condition.